The woman sitting across from me had normal thyroid labs, normal metabolic panels, and a referral from her primary care physician that read simply: ‘Patient reports fatigue and slow recovery. Labs unremarkable.’ She ran a venture-backed company in Ann Arbor, trained for marathons until two years ago, and now needed two full days to recover from a single hard workout. Her doctor had offered antidepressants. She wanted her cellular function back.
This is the gap where peptide therapy operates.
What Conventional Medicine Misses About Recovery and Repair
Most physicians are trained to recognize disease states, not declining cellular efficiency. Your labs can sit squarely within reference ranges while your mitochondria struggle, your tissue repair slows, and your metabolic signaling deteriorates. The standard approach offers NSAIDs for inflammation, stimulants for energy, and reassurance that nothing is technically wrong.
But something is wrong. Your body is receiving inadequate signals at the cellular level. Peptides are the language cells use to communicate—short chains of amino acids that bind to specific receptors and trigger precise biological responses. When those signals weaken with age, stress, or metabolic dysfunction, the downstream effects touch everything from wound healing to cognitive processing to body composition.
Conventional medicine has no framework for optimizing what still functions. It waits for frank pathology. Peptide therapy intervenes earlier, at the level of cellular communication itself. Most patients who benefit from therapeutic peptides have been told their symptoms are normal aging. The clinical literature increasingly suggests otherwise.
The Science Behind Targeted Peptide Signaling
Peptides function as cellular messengers. Unlike broad-spectrum hormones, specific peptide sequences bind to discrete receptors and activate targeted pathways. BPC-157, a synthetic derivative of a gastric protective protein, has demonstrated accelerated tendon and ligament healing in multiple animal models and emerging human case series. The mechanism appears to involve upregulation of growth factor receptors and modulation of the nitric oxide pathway.
Thymosin Beta-4, originally isolated from thymus tissue, influences actin polymerization and cell migration—critical processes in tissue repair and angiogenesis. Clinical studies published between 2023 and 2025 have examined its role in healing chronic wounds, reducing inflammation in cardiac tissue, and supporting hair follicle regeneration. The peptide does not force growth; it optimizes the cellular environment for repair processes that have stalled.
GHK-Cu, a copper-binding tripeptide, declines significantly with age—from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. It activates genes involved in collagen synthesis, antioxidant production, and metalloproteinase regulation. Recent research demonstrates its influence on cellular cleanup mechanisms and senescent cell clearance. This is not cosmetic medicine masquerading as longevity science. These are quantifiable shifts in cellular behavior with measurable downstream effects.
The challenge is precision. Peptides are not supplements. Dosing, timing, administration route, and sequence selection require clinical judgment based on specific patient goals and monitoring parameters.
What Most Patients Experience
A 52-year-old attorney came to our Ann Arbor clinic with bilateral elbow tendinopathy that had persisted for eighteen months despite physical therapy, corticosteroid injections, and activity modification. He could no longer play tennis. Grip strength had declined. His orthopedist had recommended surgical debridement as the next step.
We initiated BPC-157 per his request to his needs, targeting the affected areas. Most patients notice initial changes in pain levels within two to three weeks. He reported decreased morning stiffness at week two and improved grip strength by week four. At eight weeks, he returned to playing tennis twice weekly. At twelve weeks, imaging showed measurable improvement in tendon thickness and echogenicity.
This is a composite scenario, but it reflects a common trajectory. Peptides work with biological timelines, not pharmaceutical ones. Most patients see initial subjective improvements within two to four weeks, measurable objective changes by six to eight weeks, and sustained benefits that often persist beyond the treatment course. Not every patient responds identically. Tissue quality, inflammation burden, and metabolic health all influence outcomes. But for appropriately selected patients, peptides often accomplish what passive waiting cannot.
The Arbour Longevity Approach to Peptide Protocols
We do not offer peptide menus. We build targeted protocols based on comprehensive metabolic assessment, symptom inventory, and specific treatment goals. The initial consultation includes detailed lab work—comprehensive metabolic panel, inflammatory markers, hormone levels, and often specific biomarkers related to the patient’s primary concern.
A patient seeking improved recovery receives a different peptide strategy than one focused on metabolic optimization or cognitive support. We commonly use combinations: BPC-157 with TB-500 for musculoskeletal healing, CJC-1295 with ipamorelin for body composition and recovery, and targeted sequences like cerebrolysin or selank for cognitive applications. Dosing is individualized. Administration is taught with precision—most peptides require subcutaneous injection, and we ensure patients leave the first visit confident in technique.
Monitoring happens at structured intervals. Most protocols run eight to twelve weeks initially, with lab reassessment and symptom review at midpoint and completion. We adjust based on response. Some patients cycle peptides strategically around training or stress periods. Others use them as part of sustained optimization protocols. The medicine is elegant, but the application requires clinical oversight.
What to Expect During Your Consultation
The first visit at Arbour Longevity typically runs 45 to 60 minutes. We review your medical history, current symptoms, previous treatments, and specific goals. If peptide therapy seems appropriate, we order baseline labs—usually processed within 5-7 business days at our preferred Michigan facilities.
Once results return, we design a protocol specific to your physiology and objectives. You receive detailed written instructions, demonstration of administration technique, and direct access to clinical staff for questions during treatment. The $35 consultation fee applies toward any treatment you pursue. Most patients begin their peptide protocol within one to two weeks of the initial visit.
Follow-up happens at scheduled intervals, but we remain accessible throughout. Peptide therapy is not a passive intervention. It requires patient engagement and clinical partnership. Most patients appreciate that level of precision after years of generic advice.
What is peptide therapy used for?
Peptide therapy addresses cellular signaling deficits across multiple systems. Most patients pursue peptides for tissue healing (tendons, ligaments, post-surgical recovery), metabolic optimization (body composition, insulin sensitivity), immune modulation, cognitive support, or general recovery enhancement. The specific peptide sequence determines the primary mechanism and application. Clinical use focuses on optimizing function that has declined, not treating acute disease states.
How does peptide therapy work in the body?
Peptides are short amino acid chains that bind to specific cellular receptors and trigger targeted biological responses. Unlike hormones that create broad systemic effects, peptides influence discrete pathways—tissue repair, growth factor release, inflammation modulation, or mitochondrial function. The body already produces many of these signaling molecules, but production declines with age or metabolic stress. Therapeutic peptides supplement those signals to restore optimal cellular communication.
Is peptide therapy safe for long-term use?
Most therapeutic peptides have favorable safety profiles when used under clinical supervision at appropriate doses. Many are bioidentical or close derivatives of naturally occurring sequences. Serious adverse effects are uncommon in clinical practice. That said, long-term safety data beyond two to three years remains limited for many peptides, as therapeutic use has expanded primarily over the past decade. We typically recommend cycling rather than continuous indefinite use, and we monitor relevant biomarkers throughout treatment.
How long does it take to see results from peptide therapy?
Most patients notice initial subjective changes within two to four weeks—improved recovery time, reduced inflammation, better sleep quality, or enhanced mental clarity depending on the peptide used. Measurable objective changes in tissue healing, body composition, or metabolic markers typically emerge at six to twelve weeks. Peptides work with biological repair timelines, which are slower than pharmacological symptom suppression but often produce more durable results. Response varies based on baseline health status and specific treatment goals.
What are the side effects of peptide therapy?
Common side effects are typically mild and include injection site reactions (redness, slight swelling), transient water retention with growth hormone-releasing peptides, or flushing with certain sequences. Serious adverse effects are rare when peptides are dosed appropriately and sourced from regulated compounding pharmacies. Some peptides may influence insulin sensitivity, cortisol patterns, or fluid balance, which is why clinical monitoring matters. We review potential side effects specific to your protocol during the consultation.
Does peptide therapy work for weight loss?
Certain peptides influence body composition by affecting growth hormone release, metabolic rate, or appetite regulation. Ipamorelin, has shown effects on fat metabolism and lean mass preservation in clinical studies. However, peptides are not standalone weight loss drugs—they work best when combined with appropriate nutrition and exercise protocols. Most patients pursuing metabolic optimization see peptides as one component of a comprehensive strategy that may also include hormone optimization or GLP-1 therapy.
How much does peptide therapy cost in Ann Arbor?
Peptide therapy costs vary based on the specific sequences used, dosing protocols, and treatment duration. Most protocols range from $399 per month, depending on complexity. The initial consultation at Arbour Longevity is $35, which applies toward treatment. We provide transparent pricing during your visit once we design a protocol specific to your needs. Many patients find peptides cost-effective compared to ongoing conventional treatments that only manage symptoms without addressing underlying cellular dysfunction.
If This Resonates
If you have been told your labs are normal but your recovery is not, or if you are interested in cellular optimization beyond what conventional medicine offers, we should talk. Peptide therapy is not for everyone, but for appropriately selected patients, it often provides measurable improvements that other interventions have not.
The first step is a clinical conversation about your specific situation, symptoms, and goals. Book a consultation at arbourlongevity.com or call us at 734-436-3357. The $35 fee applies toward any treatment you pursue. We are located at 2217 Packard Street in Ann Arbor, and we work with patients throughout Michigan who are serious about optimizing how their cells function, not just managing how they feel.
Leave a Reply